Michael S. Aberman, VP Strategy and Investor Relat at REGENERON PHARMACEUTICALS INC (REGN), sold 7,500 shares at $184.85 ($1.4M) on 2012-12-11, disclosed to the SEC on 2012-12-12.
Scheduled sale ($1.4M) by VP Strategy and Investor Relat under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $182.68 | 1,257 | $230K | 16.7% |
| 2 | $182.68 | 2,875 | $525K | 38.1% |
| 3 | $184.85 | 1,268 | $234K | 17.0% |
| 4 | $185.18 | 2,100 | $389K | 28.2% |
| Total | $183.75 avg | 7,500 | $1.4M | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |